These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 11441902)

  • 1. Carvedilol in heart mitochondria: protonophore or opener of the mitochondrial K(ATP) channels?
    Oliveira PJ; Rolo AP; Sardão VA; Coxito PM; Palmeira CM; Moreno AJ
    Life Sci; 2001 Jun; 69(2):123-32. PubMed ID: 11441902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of carvedilol on isolated heart mitochondria: evidence for a protonophoretic mechanism.
    Oliveira PJ; Marques MP; Batista de Carvalho LA; Moreno AJ
    Biochem Biophys Res Commun; 2000 Sep; 276(1):82-7. PubMed ID: 11006086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitory effect of carvedilol in the high-conductance state of the mitochondrial permeability transition pore.
    Oliveira PJ; Coxito PM; Rolo AP; Santos DL; Palmeira CM; Moreno AJ
    Eur J Pharmacol; 2001 Feb; 412(3):231-7. PubMed ID: 11166286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carvedilol reduces mitochondrial damage induced by hypoxanthine/xanthine oxidase: relevance to hypoxia/reoxygenation injury.
    Oliveira PJ; Rolo AP; Palmeira CM; Moreno AJ
    Cardiovasc Toxicol; 2001; 1(3):205-13. PubMed ID: 12213973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carvedilol inhibits the exogenous NADH dehydrogenase in rat heart mitochondria.
    Oliveira PJ; Santos DJ; Moreno AJ
    Arch Biochem Biophys; 2000 Feb; 374(2):279-85. PubMed ID: 10666308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Respiratory uncoupling by increased H(+) or K(+) flux is beneficial for heart mitochondrial turnover of reactive oxygen species but not for permeability transition.
    Morota S; Piel S; Hansson MJ
    BMC Cell Biol; 2013 Sep; 14():40. PubMed ID: 24053891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Are the antioxidant properties of carvedilol important for the protection of cardiac mitochondria?
    Oliveira PJ; Gonçalves L; Monteiro P; Providencia LA; Moreno AJ
    Curr Vasc Pharmacol; 2005 Apr; 3(2):147-58. PubMed ID: 15853634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carvedilol improves energy production during acute global myocardial ischaemia.
    Monteiro P; Duarte AI; Moreno A; Gonçalves LM; Providência LA
    Eur J Pharmacol; 2003 Dec; 482(1-3):245-53. PubMed ID: 14660029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carvedilol protects against doxorubicin-induced mitochondrial cardiomyopathy.
    Santos DL; Moreno AJ; Leino RL; Froberg MK; Wallace KB
    Toxicol Appl Pharmacol; 2002 Dec; 185(3):218-27. PubMed ID: 12498738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carvedilol inhibits mitochondrial complex I and induces resistance to H2O2 -mediated oxidative insult in H9C2 myocardial cells.
    Sgobbo P; Pacelli C; Grattagliano I; Villani G; Cocco T
    Biochim Biophys Acta; 2007 Mar; 1767(3):222-32. PubMed ID: 17346667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of mitochondrial K(+) permeability and reactive oxygen species production by the p13 protein of human T-cell leukemia virus type 1.
    Silic-Benussi M; Cannizzaro E; Venerando A; Cavallari I; Petronilli V; La Rocca N; Marin O; Chieco-Bianchi L; Di Lisa F; D'Agostino DM; Bernardi P; Ciminale V
    Biochim Biophys Acta; 2009 Jul; 1787(7):947-54. PubMed ID: 19366603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carvedilol: relation between antioxidant activity and inhibition of the mitochondrial permeability transition.
    Oliveira PJ; Esteves T; Rolo AP; Monteiro P; Gonçalves L; Palmeira CM; Moreno AJ
    Rev Port Cardiol; 2003 Jan; 22(1):55-62. PubMed ID: 12712810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advantages in the use of carvedilol versus propranolol for the protection of cardiac mitochondrial function.
    Oliveira PJ; Rolo AP; Sardão VA; Monteiro P; Gonçalves L; Providência LA; Palmeira CM; Moreno AJ
    Rev Port Cardiol; 2004 Oct; 23(10):1291-8. PubMed ID: 15641294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. On the voltage dependence of the mitochondrial permeability transition pore. A critical appraisal.
    Scorrano L; Petronilli V; Bernardi P
    J Biol Chem; 1997 May; 272(19):12295-9. PubMed ID: 9139672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination of the rate of K(+) movement through potassium channels in isolated rat heart and liver mitochondria.
    Bednarczyk P; Barker GD; Halestrap AP
    Biochim Biophys Acta; 2008 Jun; 1777(6):540-8. PubMed ID: 18471430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitochondrial uncoupling, with low concentration FCCP, induces ROS-dependent cardioprotection independent of KATP channel activation.
    Brennan JP; Southworth R; Medina RA; Davidson SM; Duchen MR; Shattock MJ
    Cardiovasc Res; 2006 Nov; 72(2):313-21. PubMed ID: 16950237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective effect of carvedilol on chenodeoxycholate induction of the permeability transition pore.
    Rolo AP; Oliveira PJ; Moreno AJ; Palmeira CM
    Biochem Pharmacol; 2001 Jun; 61(11):1449-54. PubMed ID: 11331081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carvedilol inhibits the mitochondrial permeability transition by an antioxidant mechanism.
    Oliveira PJ; Esteves T; Rolo AP; Palmeira CM; Moreno AJ
    Cardiovasc Toxicol; 2004; 4(1):11-20. PubMed ID: 15034201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased potassium conductance of brain mitochondria induces resistance to permeability transition by enhancing matrix volume.
    Hansson MJ; Morota S; Teilum M; Mattiasson G; Uchino H; Elmér E
    J Biol Chem; 2010 Jan; 285(1):741-50. PubMed ID: 19880514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carvedilol and antioxidant proteins in a type I diabetes animal model.
    Diogo CV; Deus CM; Lebiedzinska-Arciszewska M; Wojtala A; Wieckowski MR; Oliveira PJ
    Eur J Clin Invest; 2017 Jan; 47(1):19-29. PubMed ID: 27805735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.